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ABSTRACT 
Modern drug discovery has led to the development of drug molecules that exhibit high lipophilicity and poor water solubility, which leads to 
problematic bioavailability. Approaches have thus been made to enhance dissolution of poorly water soluble drugs through modifications and 
creation of specific formulations. Metoclopramide is an antiemetic and gastroprokinetic agent, commonly used to treat nausea and vomiting. It 
is absorbed well after oral administration but a significant first pass effect in some human patients may reduce systemic bioavailability to 
30%.The Metoclopramide base is thus modified from Metoclopramide hydrochloride to enhance solubility .This has been achieved by the 
formulating in solid dispersion since Metoclopramide is poorly water soluble. Though it is absorbed well after oral administration,a significant 
first pass effect in some patients reduces systemic bioavailability, which can cause adverse side effects. This solid dispersion has then been used 
through transdermal drug delivery. Enhancement of solubility of poorly water soluble drug by solid dispersion may be attributed to particles 
modified characters such as particle size reduction, improved wettability, higher porosity, decreased lattice energy, amorpho us state. 
Transdermal drug delivery system has a lot of advantages such as bypassing hepatic first pass, avoidance of risks of I.V therapy, enhancing 
therapeutic efficiency and others but limitations like skin irritations are also prevalent.  
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Introduction: 
Metoclopramide chemically 4-amino-5-chloro-N-[2-(diethyl 
amino)ethyl]-2methoxybenzamide..The antiemetic action of 
Metoclopramide is due to its antagonist activity at D2 
receptors in the chemoreceptor trigger one in the central 
nervous systemand this action prevents nausea and 
vomiting triggered by most stimuli. The gastroprokinetic 
activity is mediated by muscarinic activity,D2 receptor 
antagonist activity and 5 HT-4 receptor agonist activities. It 
has a molecular weight of 299.8 and its melting point is 147 
degree Celsius. 
Enhancement of solubility of poorly water soluble drug can 
be done by solid dispersion technique.[1,2,3,4]Though there 
are simple techniques to prepare solid dispersionsproblems 
are often encountered ,such as physicochemical stability of 
drug and vehicle,making suitable formulation of solid 
dispersion of  into dosage forms and scale up of process. 
 
Fig-1:-Structure of Metoclopramide 
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R.Vijaya et, al (2012) expressed [5] that transdermal drug 
delivery delivers the drug through topical route for systemic 
effect at a predetermined andcontrolled rate. In this study, 
transdermal films of amitriptyline HCl  has been formulated 
using polymers of hydroxypropyl cellulose and polyvinyl 
pyrolidone in different compositions, the films were then 
evaluated for their physicochemical properties. 
Complexation is one such technique of preparing a solid 
dispersion,wherein the drug is bound to a carrier because of 
weak Vander waals forces and it is released from its bound 
state only when it gets exposed to a suitable chemical 
environment.In this kind of solid mixture a guest molecule 
forms complex with an inert soluble carrier(host molecule) 
in the solid state.One of the most widely used complex 
carriers is within the class of cyclodextrins[6,7,8] 
Cyclodextrins are a family of cyclic oligosaccharides 
composed of α- (1,4)linked glucopyranosesubunits.It is 
composed of interior hydrophobic  cavity, whereas the 
exterior is highly hydrophilic.The lipophilic cavity of 
cyclodextrin molecules provides a microenvironment into 
which appropriately sized non polar moieties can enter to 
form inclusion complex.[9] Complex formation between 
cyclodextrin and a substrate is assessed by its 
binding/stability constant. 
Yvaraja et al,in(2014)[10]prepared solid dispersion of 
carvedilol for enhancement of aqueous  solubility. To 
increase solubility polymers like Beta Cyclodextrin, 
Hydroxypropyl-beta-cyclodextrin were used. Thefollowing 
solid dispersion were then evaluated through phase 
solubility studies, determination of partition coefficient, 
drugcontent (%) and in vitro dissolution studies. 
Domanska et al in 2011 investigated [11] the guest host 
complex formation of three drug derivatives of 
anthranilicacid, mefenamicacid, niflumic acid with 2-
hydroxypropyl-β-cyclodextrin in aqueoussolutions. It was 
found that solubility of sparingly soluble drugs has been 
improved by the addition of 2-hydroxypropyl-β-cyclodextrin 
at two temperatures 298.15 K and 310.15 K and two pH 
values 2 and 7. 
 
 
Fig 2:-Structure of Cyclodextrin molecule 
Skin and transport through the skin: 
Human skin is a highly complex multilayered organ designed 
to keep the outside out and the insides in. It is the largest 
organ of the body comprising around 10% of the body mass 
and covers an area of approximately 1.8 square meters in a 
typical adult. In terms of drug delivery human skin can be 
considered as a series of layers which potentially provide 
series of barriers to a molecule traversing the tissue. 
The human skin[12] is divided into the following layer 
(i)The subcutaneous layer 
(ii)The dermis 
(iii)The epidermis 
(iv)The stratum corneum 
The delivery of drug molecules from a topically applied 
formulation into the systemic circulation is complex with 
numerous processes occurring and several routes of 
transport in operation. Initially drug molecules must be 
presented to the skin surface. Consequently if 
theformulation contains solid drug ,then dissolution and 
diffusion through the formulation is the initial step in 
delivery. If the formulation contains dissolved drug,then as 
molecules nearest to skin surface [13,14]enter the tissue these 
must be replaced by other molecules diffusing within the 
formulation towards the skin surface.Once at the outer layer 
of the stratum corneum, the drug molecule has three 
potentialroutes to cross the skin. 
Transdermal drug delivery system: 
Transdermal drug delivery systems are defined as self 
contained, discrete dosage forms which applied to the skin 
and deliver the drug, through the skin at controlled rate to 
the systemic circulation at a sufficient concentration to 
ensure the therapeutic efficacy.These are suitable for drugs 
that need to be administered for diseases those are chronic 
in nature. 
B.Anroopet al.,(2014) [15]in the work studied that, co-
aadministration of levodopa and carbidopa through skin 
using a drug in adhesive transdermal system and assessed 
the formulation by the methods of in-vitro release,ex-vivo 
permeation ,and in vivo pharmacokinetics in rat model. This 
study therefore encloses that the transdermal delivery route 
[16,,17,18,19]could be a feasible alternative to oral therapy for 
the successful delivery of levodopa in Parkinson’s disease.   
B. Anroop[20]et al worked on the transdermal delivery 
system of Vildagliptin and its comparison with oral therapy. 
Ali M.M et al.,in this study,[21]to prepare adomperidone 
transdermal adhesive matrix patch to improve its 
therapeutic efficacy ,patient compliance and to reduce the 
frequency of dosing and side effects,as well to avoid its 
extensive first pass metabolism.And then evaluate the 
physicochemical and mechanical properties as well as to in 
vitro release and rat skin permeation of domperidone. 
Different formulas of the patches were prepared by solvent 
using Chitosan, Eudragit E100,Eudragit RS 100 as polymers 
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with many suitable plasticizer. The physicochemical 
parameters were then evaluated. 
The transdermal drug delivery system which use the skin as 
the port of drug administration and bypass the hepatic first 
pass metabolism to maintain a constant and prolonged 
therapeutic blood level of drug in the body. Skin is an 
important site of drug application for both local and 
systemic effects.topical and transdermal products remain 
key formulation for delivering drugs not only to the skin,but 
also through it for systemic action. 
Ideal properties of a drug that can be used for transdermal 
drug delivery system- 
(i)Dose should be less than 20 mg/day 
(ii)Molecular weight should be less than 400 Dalton 
(iii)Melting point of drug should be less than 300 degree 
Celsius 
(iv)Partition coefficient should be between -1 to 4 
(v)Skin permeability coefficient more than 0.5 * 10^(-3) 
cm/h 
(vi)Skin reaction must be non irritant and non sensitizing 
(vii)Therapeutic index must be low. 
The Biopharmaceutics classification system: 
It is a system to differentiate drugs on the basis of their 
solubility and permeability. It is a guide for predicting the 
intestinal drug absorption provided by the U.S Food and 
Drug Administration.  
According to the Biopharmaceutics[22,23,24,25]Classification 
System, drug substances are classified as follows: 
1. Class I-high permeability, high solubility: Those 
compounds are well absorbed and their absorption rate is 
usually higher than excretion. 
2. Class II-high permeability, low solubility: The 
bioavailability of those products is limited by their solvation 
rate. 
3. Class III-low permeability, high solubility: The absorption 
is limited by the permeation rate but the drug is solvated 
very fast. If the formulation does not change the 
permeability or gastro-intestinal duration time, then Class I 
criteria can be applied. 
4. Class I-high permeability, high solubility: 
Thosecompounds have a poor bioavailability. Usually they 
are not well absorbed over the intestinal mucosa and a high 
variability is expected. 
Preparation and Characterization of 
Metoclopramide Solid dispersion: 
Many drugs are under great challenge owing to their poor 
aqueous solubility and dissolution rates.  As per BCS 
classification both solubility and permeability of a drug 
regulate extent of maximum absorbable dose. Here, the 
Metoclopramide base and carrier(HPβCD, poloxamer 
188,PVP K30) were dispersed in a mixture of ethanol and 
dichloromethane to produce a  clear solution by stirring in a 
magnetic stirrer at room temperature, upon removal of 
solvent solid powder was obtained. 
Conversion of Metoclopramide Hydrochloride to 
Metoclopramide Base form: 
Metoclopramide base form is required which is usually 
available in its in its hydrochloride form. Required amount  
of Metoclopramide hydrochloride was  dispersed in 
sufficient double distilled water  followed by stirring until 
the total amount of drug gets fully dissolved. Thesolution 
was neutralized by 1 M sodium hydroxide solution and 
gradually a precipitate was formed. The precipitate was 
collected by filtration and the precipitate thus obtained was 
washed several times with double distilled water to remove 
HCl which was produced during precipitation. The wet 
precipitate was dried in hot air oven at 50 degrees Celsius. 
Afterwards the solid material was cooled up to room 
temperature (25 degrees Celsius).Next; dried solid material 
was treated with acetone to make a saturated solution ad 
stirred continuously at 50 degree Celsius. The solution was 
allowed to attain room temperature and thereafter it was 
kept in a refrigerator and crystal particles of 
Metaclopramide (base form) was formed and collected and 
dried in 50 degrees Celsius in hot air oven. The material was 
cooled at room temperature and it was weighed. 
Preparation of Metoclopramide Solid dispersion: 
Various methods of preparation of solid dispersion had been 
reported in earlier literature such as Fusion method, Solvent 
evaporation technique, Kneading methods and use of surface 
active agents. 
Solvent evaporation technique was carried out by dispersing 
physical mixture and polymer at certain common ratio and 
then it was evaporated until transparent solvent free thin 
layer of mass was obtained. Then the film was dried till 
constant weight at 50 degrees Celsius 
Sadozai et al.,(2013) The objective of this study[26] was to 
prepare and evaluate sustained release matrix tablets of 
domperidone using xanthan gum as a sustaining material in 
different drug to polymer ratios prepared by two different 
techniques by wet granulation and solvent evaporation and 
effect on release pattern by wet granulation and solvent 
evaporation and effect on release pattern by changing the 
preparation technique. Formulation prepared by wet 
granulation and solvent evaporation technique and showed 
that the sustaining effect of xanthan gum was directly 
proportional to the concentration of polymer used. It was 
observed that by changing the method of preparation from 
wet granulation to solvent evaporation the drug release 
becomes constant and no fluctuation was observed as 
compared to wet granulation technique the drug release 
profile shows little fluctuation due to uneven distribution of 
drug and polymer. 
Characterization of Metoclopramide solid dispersion: 
Characterization of solid dispersion was performed by 
instrumental analysis like Fourier Transform Infrared 
Spectroscopy (FTIR) analysis and Differential Scanning 
Calorimetry (DSC) analysis[27, 28]. FTIR analysis was done to 
observe the stability of drug and also to confirm drug 
polymer interaction if any.DSC analysis was carried out for 
Metoclopramide loaded solid dispersions, physical mixture 
and also for pure drug to analyze the crystallinity and 
amorphous nature of compounds.  
Studies such as aqueous solubility study, Dissolution study, 
Ex-vivo permeation study, in vitro diffusion study was also 
performed. 
Solubility of pure drug Metoclopramide increases in acidic 
pH. Metoclopramide is sparingly soluble in double distilled 
water. Its aqueous solubility in double distilled water 
increases linearly keeping drug amount fixed when fraction 
of carrier substance (HPβCD) in solid dispersion is 
increased. Various solubility data were compared and it was 
observed that solubility of drug in pH 5.5 was 28.95 times 
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greater than that of pure drug in double distilled water 
samples without any carrier substances. 
The solubility of Metoclopramide base drug was enhancedby 
using ionization process and various carriers like HPβCD, 
PVP K-30, Poloxamer-188. The phase solubility study gave a 
support to explain drug carrier complexation on the basis of 
thermodynamic parameters. The dissolution rate and 
solubility of prepared solid dispersions were dramatically 
improved when compared  to that of pure drug, this 
happened because of conversion of drug from crystalline to 
amorphous nature and formation of complexation between 
drug and hydrophilic carriers. When solid dispersion was 
prepared using various carriers, the solid dispersion of drug 
with HPβCD by ion solvent evaporation technique showed 
better dissolution rate in pH 7.4. 
The FTIR spectroscopy of Metoclopramide confirmed that 
some interaction between the drug and carrier may occur 
because of hydrogen bonding in hydroxyl group of carrier 
whereas the DSC study suggested that base drug is 
completely converted to amorphous state in solid dispersion 
form. 
After enhancing the solubility and dissolution rate of poorly 
soluble drug. The development of dosage form is often 
necessary to achieve the desired release pattern and 
effective therapeutic response. Therefore to achieve as well 
as to maintain the drug concentration within the 
therapeutically effective range the prepared 
Metoclopramide base solid dispersion was developed as a 
transdermal drug delivery system using controlled release 
polymers and 3M backing layer membrane. Transdermal 
patches were thus formulated. 
The ex-vivo study when performed of those patches through 
the pig ear skin in Franz diffusion cell in phosphate 0.9% 
saline buffer pH 7.4 at a constant temperature 37 degree 
Celsius in 30 minutes time interval. Among all the 
patchesthatwas formed MET:HPβCD (1:5) (patch C) showed 
that the controlled release permeationMET:PLX (1:5)[patch 
D] was permeate slowly through the skin. 
Conclusion: 
Several double distilled water formulation strategies have 
been proposed to overcome the problems of solubility, 
which is a well known problem. Though there have been 
loads of research efforts made, there are a very few 
successful marketed formulations available in the market. To 
counter this problem, development of solid dispersion is a 
very promising approach and it holds a key position among 
various other strategies proposed. Development of solid 
dispersion is thus done to enhance aqueous solubility and 
thus to ensure oral bioavailability of poorly soluble drugs. 
But only very few solid dispersion products are available in 
the market due to stability factors.Various processing 
parameters that are involved in the development of solid 
dispersion affect the effectiveness, stability[29,30], usefulness  
and safety of the formulation prepared which in turn affects 
the fact that whether  it can be marketed or not.The use of 
systemic experimental design along with mathematical 
optimization is both time and cost efficient and its 
application assures the formulation quality.  
Thus this review provides a brief insight of research works 
performed by various scientists relating to solid dispersion 
and using it for transdermal drug delivery system. 
Formulating solid dispersions is a  promising field and in 
future can be used thoroughly for preparing formulations for 
sparingly soluble drugs. However, not much research has 
been done to check its therapeutic efficacy of the drug 
molecule when formulated in solid dispersions remains the 
same or not , and this is therefore an area that can still be 
explored a lot. We must also try to prepare formulations 
other than solid dispersions for sparingly soluble drugs as 
solid dispersions have stability problems in the physiological 
systems.  
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